798-15079-39498
2 vaccinations
7 coded responses
10 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 286 / NC
- Registered
- 2021-08-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-11
Registered in v-safe
-
2021-08-11
Dose 1 — Pfizer-BioNTech
- 2021-08-11
-
2021-08-12
Survey response — days 1–6 daily, dose 1MedDRA: Eye pain, Photophobia — Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore eye sockets. Light sensitiveMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-08-14
Survey response — days 1–6 daily, dose 1MedDRA: Cough — Feeling: Fair · Headache, Fatigue or tirednessFree text: CoughMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-15
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea — Feeling: Fair · Fatigue or tirednessFree text: Short of breath on exertionMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-16
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Dyspnoea — Feeling: Fair · Site: Itching · Be unable to do your normal daily activitiesFree text: Cough short of breath,MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-17
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea exertional — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Short of breath on exertionMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-25
Survey response — day 14, dose 1MedDRA: Asthenia, Dizziness exertional, Dyspnoea, Fatigue, Loss of personal independence in daily activities — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Feel weak, short of breath and lightheaded on exertion, very tired I am working but have no energy to complete tasks at home and it is hard to get through the workdayMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-01
Dose 2 — Pfizer-BioNTech
- 2021-09-22
-
2022-03-02
Survey response — 6 months, dose 2MedDRA: Dyspnoea exertional, Fatigue, Heart rate increased, Office visit, Palpitations — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Heart palpatations, shortness of breath on exertion, extreme fatigue, very high resting pulse rate · Healthcare visit (other): Seeing cardiologist and pulmonologist , had echocardiogram, bubble test, Lexiscan and ct of chest- no results yetMedDRA releases: 2024-11 · check-in free text available
-
2022-03-02
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-04
- 2022-03-07
-
2022-03-07
Callback requested for05:30PMPM
- 2022-03-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-11 | Pfizer-BioNTech | No |
| 2 | 2021-09-01 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Sore eye sockets. Light sensitive
Systemic reaction (other): Cough
Systemic reaction (other): Short of breath on exertion
Systemic reaction (other): Cough short of breath,
Systemic reaction (other): Short of breath on exertion
Release 9 — day 14, dose 1
Symptoms: Feel weak, short of breath and lightheaded on exertion, very tired I am working but have no energy to complete tasks at home and it is hard to get through the workday
Release 11 — 6 months, dose 2
Symptoms: Heart palpatations, shortness of breath on exertion, extreme fatigue, very high resting pulse rate
Healthcare visit (other): Seeing cardiologist and pulmonologist , had echocardiogram, bubble test, Lexiscan and ct of chest- no results yet
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Asthenia | ✓ | · | ✓ |
| SD | Dizziness exertional | ✓ | · | ✓ |
| SD | Dyspnoea | ✓ | · | ✓ |
| SD | Dyspnoea exertional | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Loss of personal independence in daily activities | ✓ | · | ✓ |
| SD | Palpitations | · | · | ✓ |
| SRO | Cough | ✓ | · | ✓ |
| SRO | Dyspnoea | ✓ | · | ✓ |
| SRO | Dyspnoea exertional | ✓ | · | ✓ |
| SRO | Eye pain | ✓ | · | ✓ |
| SRO | Photophobia | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release